Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

PHASE3CompletedINTERVENTIONAL
Enrollment

589

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

Agomelatine (AGO178C)

DRUG

Placebo

Trial Locations (45)

10021

Eastside Comprehensive Medical Service, New York

11235

Social Psychiatric Research Institute, Brooklyn

19139

CRI Worldwide, LLC - Kirkbride Division, Philadelphia

21208

Pharmasite Research, Pikesville

29406

Medical University of South Carolina, North Charleston

30306

Emory University, Atlanta

32701

ICSL Clinical Studies, Altamonte Springs

33134

Arocha Research Center, Coral Gables

33143

Miami Research Associates, South Miami

33145

Innova Clinical Trials, Miami

34208

Florida Clinical Research Center, LLC, Bradenton

35294

University of Alabama at Birmingham, Department of Psychiatry, Birmingham

38119

CNS Healthcare, Memphis

Research Strategies, Memphis

43623

Neurology & Neuroscience Center of Ohio, Toledo

44718

Neurobehavioral Clinical Research, Canton

45219

University of Cincinnati Medical Center, Cincinnati

47713

Deaconess Clinic, Evansville

60068

CNS Clinical Trials, Park Ridge

60169

Alexian Brothers Center for Psychiatric Research, Hoffman Estates

60435

Joliet Center for Clinical Research, Joliet

63141

Mercy Health Research, St Louis

67207

Heartland Research Associates, LLC, Wichita

68510

Premier Psychiatry Group, LLC, Lincoln

73112

SP Research, Oklahoma City

77008

Claghorn-Lesem Research Clinic, Inc., Houston

78731

FutureSearch Trials, Austin

84132

University of Utah, Department of Psychiatry, Salt Lake City

91403

California Neuroscience Research Medical Group, Inc., Sherman Oaks

92108

Affiliated Research Institute, San Diego

92243

Valley Clinical Research, El Centro

92374

Anderson Clinical Research, Redlands

92591

Viking Clinical Research, Temecula

92626

ATP Clinical Research, Costa Mesa

92845

Collaborative Neuroscience Network, Garden Grove

92868

University of California, Irvine Medical Center, Orange

97210

Summit Research Network, Portland

97404

Willamette Valley Clinical Studies, Eugene

98007

Northwest Clinical Research Center, Bellevue

98104

Summit Research, Seattle

02114

Massachusetts General Hospital, Boston

02135

Boston Clinical Trials, Brighton

08046

CRI Worldwide, LLC - Lourdes Division, Willingboro

00959

Caribbean Research and Education Center, Bayamón

00907

Dharma Institute and Research Center, San Juan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY